Log In
Print
BCIQ
Print
Print this Print this
 

BF2.649

  Manage Alerts
Collapse Summary General Information
Company Bioprojet Pharma S.a.r.l.
DescriptionHistamine H3 receptor antagonist
Molecular Target Histamine H3 receptor (HRH3)
Mechanism of ActionHistamine H3 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationExcessive sleepiness
Indication DetailsTreat narcolepsy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today